Tele Health Monitoring: Improving Quality of Life for End Stage Amyloidosis Patients

2.50
Hdl Handle:
http://hdl.handle.net/10755/164611
Category:
Abstract
Type:
Presentation
Title:
Tele Health Monitoring: Improving Quality of Life for End Stage Amyloidosis Patients
Author(s):
Primiani, Stephanie; Castillo, Carmen
Author Details:
Stephanie Primiani, BSN, RN, Memorial Sloan-Kettering Cancer Center, New York, New York, USA, email: rnstat@gmail.com; Carmen Castillo, RN, BSN
Abstract:
Clinical/Evidence Based Practice: Improving quality of life in end stage cancer patients is an important focus in oncology nursing. This is true in patients with Primary Amyloidosis, a B cell dyscrasia that often goes undiagnosed until the late stages of disease. Median survival is 13.2 months. Patients commonly have symptoms of dyspnea, fluid overload, and hypotension. Supportive care and symptom management is crucial and can reduce recurrent visits. To this end, a team of nurses at this NCI designated comprehensive cancer center implemented a Telehealth Monitoring (THM) pilot project. The goal was to remotely monitor vital signs, daily weights, diet, and medication management at home. To reduce the frequency of hospital admissions, urgent care, and clinic visits, and improve quality of life for patients and their families. Patients with cardiac or renal involvement with amyloidosis who require diuretics to manage post-chemotherapy symptoms and symptoms of congestive heart failure were identified. To date, six patients have participated. A digital monitoring system was installed in the patient's home to record vital signs and daily weight. Results were transmitted electronically via modem to the home care agency and designated provider who evaluated trends. Abnormal values prompted an RN visit to the patient's home for further evaluation. The home care nurse communicated with the office practice nurse to determine appropriate interventions. THM is an effective home management strategy for this patient population. It has reduced trips to the clinic for vital signs, weight monitoring and medication management. Since pre-implementation, patient visits decreased from thirty five to nine. It has reduced hospital readmissions and visits to the urgent care center. It has provided more effective symptom management. Patients and families report, improved quality of life while having a more active role in their care. Though small, this pilot demonstrates successful home monitoring of a tenuous cancer population. THM can be applied to other oncology practices to better manage care of symptoms related to active treatment. We plan to expand THM to other oncology patient populations.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2009
Conference Name:
34th Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
San Antonio, Texas, USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleTele Health Monitoring: Improving Quality of Life for End Stage Amyloidosis Patientsen_GB
dc.contributor.authorPrimiani, Stephanieen_US
dc.contributor.authorCastillo, Carmenen_US
dc.author.detailsStephanie Primiani, BSN, RN, Memorial Sloan-Kettering Cancer Center, New York, New York, USA, email: rnstat@gmail.com; Carmen Castillo, RN, BSNen_US
dc.identifier.urihttp://hdl.handle.net/10755/164611-
dc.description.abstractClinical/Evidence Based Practice: Improving quality of life in end stage cancer patients is an important focus in oncology nursing. This is true in patients with Primary Amyloidosis, a B cell dyscrasia that often goes undiagnosed until the late stages of disease. Median survival is 13.2 months. Patients commonly have symptoms of dyspnea, fluid overload, and hypotension. Supportive care and symptom management is crucial and can reduce recurrent visits. To this end, a team of nurses at this NCI designated comprehensive cancer center implemented a Telehealth Monitoring (THM) pilot project. The goal was to remotely monitor vital signs, daily weights, diet, and medication management at home. To reduce the frequency of hospital admissions, urgent care, and clinic visits, and improve quality of life for patients and their families. Patients with cardiac or renal involvement with amyloidosis who require diuretics to manage post-chemotherapy symptoms and symptoms of congestive heart failure were identified. To date, six patients have participated. A digital monitoring system was installed in the patient's home to record vital signs and daily weight. Results were transmitted electronically via modem to the home care agency and designated provider who evaluated trends. Abnormal values prompted an RN visit to the patient's home for further evaluation. The home care nurse communicated with the office practice nurse to determine appropriate interventions. THM is an effective home management strategy for this patient population. It has reduced trips to the clinic for vital signs, weight monitoring and medication management. Since pre-implementation, patient visits decreased from thirty five to nine. It has reduced hospital readmissions and visits to the urgent care center. It has provided more effective symptom management. Patients and families report, improved quality of life while having a more active role in their care. Though small, this pilot demonstrates successful home monitoring of a tenuous cancer population. THM can be applied to other oncology practices to better manage care of symptoms related to active treatment. We plan to expand THM to other oncology patient populations.en_GB
dc.date.available2011-10-27T12:03:50Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:03:50Z-
dc.conference.date2009en_US
dc.conference.name34th Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationSan Antonio, Texas, USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.